The protection afforded by a single dose of either Pfizer or Astra is sufficiently low, in the case of the Indian variant, that the calculus has changed. It is no longer advantageous to get as many people as possible single-dosed - it’s important to get the second dose into people quickly. Some emerging data here:
https://www.bbc.co.uk/news/uk-57214596